Index of reports
> Cases with Fatigue (165)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 165 Next >>
Possible Dexamethasone side effects in female
Reported by a pharmacist from United States on 2012-08-15
Patient: female, weighing 63.6 kg (139.9 pounds)
Reactions: Pruritus, Varicose Vein, Nasal Congestion, DRY Skin, Micturition Urgency, Migraine With Aura, Fatigue, Dysphonia, Heart Rate Increased, DRY Mouth, Dehydration, Gastrooesophageal Reflux Disease, Hypertension, Decreased Appetite, Muscle Spasms
Drug(s) suspected as cause:
Dexamethasone
Dosage: 5.7143 milligram
Administration route: Oral
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-08
Other drugs received by patient: Potassium
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: male, weighing 91.2 kg (200.5 pounds)
Reactions: Lymphadenopathy, Wound Haemorrhage, Upper Respiratory Tract Infection, Dermatitis, Blister, Hypotension, Left Ventricular Hypertrophy, Pancytopenia, Skin Hypertrophy, Diverticulum, Compression Fracture, Metastases To Spine, Swelling, Osteoporosis, Exposed Bone in JAW, Calcification Metastatic, Chest Pain, Malignant Melanoma, Bone Disorder, Decreased Appetite, Facet Joint Syndrome, Arthralgia, Mitral Valve Incompetence, Lung Infiltration, Primary Sequestrum, Osteomyelitis, Erythema, Dyspepsia, Oedema Mucosal, Carpal Tunnel Syndrome, Radiculopathy, Cough, Abscess Limb, Pneumonia, Cellulitis, Pain in Extremity, Supraventricular Tachycardia, Anaemia, Benign Prostatic Hyperplasia, Renal Cyst, Decreased Interest, Aortic Valve Incompetence, Soft Tissue Disorder, Dyslipidaemia, Increased Upper Airway Secretion, Haemorrhage, Pain, Biopsy, Bone Erosion, Fatigue, Dyspnoea Exertional, Pleural Effusion, Dizziness, RIB Fracture, Atrial Flutter, Bone Lesion, Local Swelling, Varicose Vein, Osteolysis, Neck Mass, Tenosynovitis, Hyperlipidaemia, Osteoarthritis, Anxiety, Neoplasm Malignant, Osteonecrosis of JAW, Spinal Osteoarthritis, Hypertension, Infection
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Start date: 2002-02-01
End date: 2003-10-06
Dexamethasone
Revlimid
Zometa
Dosage: 3.5 mg monthly
Start date: 2003-11-01
End date: 2005-09-01
Zometa
Dosage: 4 mg, qmo
Indication: Multiple Myeloma
Start date: 2003-11-03
End date: 2005-10-10
Other drugs received by patient: Thalidomide; Plavix; Calcium Carbonate; Melphalan Hydrochloride; Zantac; Calcium Carbonate; Lortab; Glyburide
Possible Dexamethasone side effects in
Reported by a physician from Canada on 2012-08-10
Patient:
Reactions: Confusional State, Motor Dysfunction, Hyperglycaemia, Aphasia, Headache, Transaminases Increased, Myopathy, Hepatic Steatosis, Fatigue, Mental Disorder
Drug(s) suspected as cause:
Dexamethasone
Dosage: 12 mg, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Dexamethasone
Dosage: 8 mg, qd
Dexamethasone
Dosage: 12 mg, qd
Dexamethasone
Dosage: 4 mg, qd
Dexamethasone
Dosage: 16 mg, qd
Dexamethasone
Dosage: 12 mg, qd
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Temodal
Dosage: 200 mg/m2, qd
Administration route: Oral
Temodal
Dosage: 75 mg/m2, qd
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 107.1 kg (235.7 pounds)
Reactions: Drug Dose Omission, Protein Urine Present, Contusion, Hyperglycaemia, Malaise, Fatigue, Renal Impairment, Insomnia, Platelet Count Decreased, Blood Test Abnormal
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-06-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-29
End date: 2011-09-29
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-11-25
End date: 2012-01-01
Other drugs received by patient: Multi-Vitamins; BEE Pollen; Amlodipine; Lisinopril; Eplerenone; Furosemide; Vitamin D; Pravastatin; Carvedilol; Omeprazole; Oxybutynin Chloride; Garlic; Warfarin Sodium; Coenzyme Q10; Ferrous Sulfate TAB; Fish OIL; Caltrate + D; Metformin Hydrochloride; Prolia
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 91.2 kg (200.5 pounds)
Reactions: Lymphadenopathy, Wound Haemorrhage, Dermatitis, Upper Respiratory Tract Infection, Blister, Hypotension, Left Ventricular Hypertrophy, Pancytopenia, Diverticulum, Compression Fracture, Metastases To Spine, Swelling, Osteoporosis, Exposed Bone in JAW, Calcification Metastatic, Chest Pain, Malignant Melanoma, Bone Disorder, Decreased Appetite, Facet Joint Syndrome, Arthralgia, Mitral Valve Incompetence, Lung Infiltration, Primary Sequestrum, Osteomyelitis, Erythema, Dyspepsia, Oedema Mucosal, Carpal Tunnel Syndrome, Radiculopathy, Cough, Pneumonia, Cellulitis, Pain in Extremity, Anaemia, Supraventricular Tachycardia, Benign Prostatic Hyperplasia, Renal Cyst, Decreased Interest, Aortic Valve Incompetence, Soft Tissue Disorder, Dyslipidaemia, Increased Upper Airway Secretion, Haemorrhage, Pain, Biopsy, Bone Erosion, Dyspnoea Exertional, Fatigue, Dizziness, Pleural Effusion, RIB Fracture, Atrial Flutter, Bone Lesion, Local Swelling, Osteolysis, Neck Mass, Varicose Vein, Anxiety, Osteoarthritis, Hyperlipidaemia, Neoplasm Malignant, Osteonecrosis of JAW, Spinal Osteoarthritis, Hypertension, Infection
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Start date: 2002-02-01
End date: 2003-10-06
Dexamethasone
Revlimid
Zometa
Dosage: 4 mg, qmo
Indication: Multiple Myeloma
Start date: 2003-11-03
End date: 2005-10-10
Zometa
Dosage: 3.5 mg monthly
Start date: 2003-11-01
End date: 2005-09-01
Other drugs received by patient: Zantac; Lortab; Glyburide; Calcium Carbonate; Melphalan Hydrochloride; Calcium Carbonate; Thalidomide; Plavix
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride
Possible Dexamethasone side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-06
Patient: 65 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Hypersensitivity, Pain, Anaemia, Rash, Multiple Myeloma, Pyrexia, Constipation, Fatigue, Granulocytopenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Myeloma Recurrence
Start date: 2009-10-01
End date: 2009-10-21
Revlimid
Administration route: Oral
Indication: Myeloma Recurrence
Start date: 2009-10-01
End date: 2009-10-21
Other drugs received by patient: Filgrastim; Levofloxacin; Levofloxacin; Filgrastim; Filgrastim; Filgrastim; Ribodronat; Heparin
Possible Dexamethasone side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-02
Patient: male, weighing 91.2 kg (200.5 pounds)
Reactions: Primary Sequestrum, Lymphadenopathy, Osteomyelitis, Erythema, Wound Haemorrhage, Dermatitis, Dyspepsia, Upper Respiratory Tract Infection, Oedema Mucosal, Carpal Tunnel Syndrome, Radiculopathy, Cough, Cellulitis, Pneumonia, Anaemia, Supraventricular Tachycardia, Hypotension, Left Ventricular Hypertrophy, Benign Prostatic Hyperplasia, Pancytopenia, Renal Cyst, Decreased Interest, Diverticulum, Compression Fracture, Metastases To Spine, Aortic Valve Incompetence, Soft Tissue Disorder, Dyslipidaemia, Increased Upper Airway Secretion, Osteoporosis, Haemorrhage, Exposed Bone in JAW, Pain, Biopsy, Bone Erosion, Calcification Metastatic, Dyspnoea Exertional, Fatigue, Chest Pain, Pleural Effusion, Malignant Melanoma, Dizziness, Bone Disorder, Decreased Appetite, RIB Fracture, Atrial Flutter, Bone Lesion, Osteolysis, Local Swelling, Neck Mass, Varicose Vein, Facet Joint Syndrome, Osteoarthritis, Hyperlipidaemia, Anxiety, Arthralgia, Neoplasm Malignant, Osteonecrosis of JAW, Mitral Valve Incompetence, Spinal Osteoarthritis, Lung Infiltration, Hypertension, Infection
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Start date: 2002-02-01
End date: 2003-10-06
Dexamethasone
Revlimid
Zometa
Dosage: 4 mg, qmo
Indication: Multiple Myeloma
Start date: 2003-11-03
End date: 2005-10-10
Zometa
Dosage: 3.5 mg monthly
Start date: 2003-11-01
End date: 2005-09-01
Other drugs received by patient: Lortab; Zantac; Thalidomide; Calcium Carbonate; Melphalan Hydrochloride; Glyburide; Plavix; Calcium Carbonate
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-07-31
Patient: male, weighing 91.2 kg (200.5 pounds)
Reactions: Primary Sequestrum, Lymphadenopathy, Osteomyelitis, Erythema, Wound Haemorrhage, Upper Respiratory Tract Infection, Dyspepsia, Oedema Mucosal, Carpal Tunnel Syndrome, Radiculopathy, Cough, Cellulitis, Pneumonia, Hypotension, Supraventricular Tachycardia, Anaemia, Benign Prostatic Hyperplasia, Left Ventricular Hypertrophy, Pancytopenia, Renal Cyst, Decreased Interest, Diverticulum, Metastases To Spine, Compression Fracture, Aortic Valve Incompetence, Soft Tissue Disorder, Dyslipidaemia, Increased Upper Airway Secretion, Haemorrhage, Osteoporosis, Exposed Bone in JAW, Pain, Biopsy, Bone Erosion, Calcification Metastatic, Fatigue, Dyspnoea Exertional, Chest Pain, Malignant Melanoma, Dizziness, Pleural Effusion, Bone Disorder, Decreased Appetite, RIB Fracture, Atrial Flutter, Bone Lesion, Osteolysis, Varicose Vein, Facet Joint Syndrome, Neck Mass, Osteoarthritis, Hyperlipidaemia, Anxiety, Arthralgia, Neoplasm Malignant, Osteonecrosis of JAW, Mitral Valve Incompetence, Spinal Osteoarthritis, Lung Infiltration, Hypertension, Infection
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Start date: 2002-02-01
End date: 2003-10-06
Dexamethasone
Revlimid
Zometa
Dosage: 3.5 mg monthly
Start date: 2003-11-01
End date: 2005-09-01
Zometa
Dosage: 4 mg, qmo
Indication: Multiple Myeloma
Start date: 2003-11-03
End date: 2005-10-10
Other drugs received by patient: Calcium Carbonate; Calcium Carbonate; Zantac; Melphalan Hydrochloride; Lortab; Plavix; Thalidomide; Glyburide
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-23
Patient: male, weighing 54.0 kg (118.8 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 135 mg
Mercaptopurine
Dosage: 8000 mg
Methotrexate
Dosage: 270 mg
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Dexamethasone side effects in
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient:
Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2007-11-05
End date: 2007-12-03
Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin
Possible Dexamethasone side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10
Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Prostate Cancer, Anaemia, Cushing's Syndrome, Dysgeusia, Osteoarthritis, Syncope, Neuropathy Peripheral, Fatigue, Arthralgia, Carbuncle, Dehydration, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 milligram
Indication: Prostate Cancer
Start date: 2008-10-01
Dexamethasone
Dosage: 1.5 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2008-10-01
Dexamethasone
Dosage: 1.5 milligram
Dexamethasone
Dosage: .75 milligram
Administration route: Oral
Start date: 2009-04-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-04-15
End date: 2011-06-09
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-06-10
End date: 2011-08-03
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2009-12-18
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2009-09-14
End date: 2009-12-17
Other drugs received by patient: Acetylsalicylacid; Metformin HCL; Metoprolol
Possible Dexamethasone side effects in 62 year old male
Reported by a physician from United Kingdom on 2012-07-03
Patient: 62 year old male
Reactions: Fatigue, Diarrhoea, Nausea, Pulmonary Embolism, Electrolyte Imbalance, Lower Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg;;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-01-05
End date: 2010-02-26
Velcade
Dosage: 2.5 mg;;iv, 1.3 mg;;iv
Indication: Multiple Myeloma
Start date: 2010-03-29
End date: 2010-03-29
Velcade
Dosage: 2.5 mg;;iv, 1.3 mg;;iv
Indication: Multiple Myeloma
Start date: 2010-01-05
Other drugs received by patient: Acyclovir; Fluconazole; Dexamethasone; Fentanyl; Furosemide; Lansoprazole; Melphalan Hydrochloride; Vincristine; Doxorubicin HCL; Metformin Hydrochloride; Pioglitazone; Cyclophosphamide; Thalidomide; Glimepiride
Possible Dexamethasone side effects in female
Reported by a lawyer from United States on 2012-07-02
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-02
Patient:
Reactions: Anaemia, Pulmonary Embolism, Sudden Death, Rash, Macular Oedema, Cardiac Disorder, Fatigue, Sepsis, Cardiac Arrest, Thrombocytopenia, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Dexamethasone
Dosage: 5.7143 milligram
Revlimid
Administration route: Oral
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: male, weighing 128.1 kg (281.8 pounds)
Reactions: Musculoskeletal Pain, Anaemia, Mental Status Changes, Multiple Myeloma, Hypercalcaemia, Osteonecrosis, Fatigue, Gait Disturbance, Thrombocytopenia, Pathological Fracture
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytoxan
Dexamethasone
Indication: Product Used FOR Unknown Indication
Etoposide
Indication: Product Used FOR Unknown Indication
Revlimid
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: unk
Start date: 2012-05-03
Velcade
Dosage: 1.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-03-07
End date: 2012-04-23
Other drugs received by patient: Metoprolol Succinate; Ramipril; Duloxetime Hydrochloride; Glucophage; Catapres / 00171101 /; Allopurinol; Cymbalta; Percocet; Zometa; Ativan; Ascriptin A / D
Possible Dexamethasone side effects in female
Reported by a physician from Spain on 2012-06-29
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: Fatigue, Vomiting, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-03-28
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-03-29
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-03-28
Ofatumumab
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-03-27
Other drugs received by patient: Pregabalin; Ondansetron; Ciprofloxacin; Pregabalin; Linezolid; Furosemide; Sulfamethoxazole and Trimethoprim; Pregabalin; Metoclopramide; Ceftazidime; Folic Acid; Omeprazole; Lorazepam; Tramadol HCL; Pegfilgrastim; Chlorpromazine HCL; Acetaminophen; Calcium Carbonate + Cholecalciferol; Metamizol; 6alpha-Methylprednisolone
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-29
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure
Drug(s) suspected as cause:
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s) subcutaneous
Indication: Chemotherapy
Paclitaxel
Dosage: see image
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Paclitaxel
Dosage: see image
Indication: Breast Cancer
End date: 2011-07-05
Ranitidine
Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: (Docusate); (Biotene / 00203502 / )
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-28
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-28
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-27
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-06-25
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Fatigue, Chest Discomfort, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Chlorpheniramine TAB
Dosage: 10 mg, unk, iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg, iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone (Domperidone)
Dosage: 20 mg, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315;300 mg, qow, iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Paclitaxel
Dosage: 315;300 mg, qow, iv
Indication: Breast Cancer
End date: 2011-07-05
Pegfilgrastim (Pegfilgrastim)
Dosage: 6 mg, sc
Indication: Product Used FOR Unknown Indication
Ranitidine Hydrochloride
Dosage: 50 mg, iv
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Biotene; Doxorubicin HCL; Cyclophosphamide; Docusate
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Dexamethasone side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue
Drug(s) suspected as cause:
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neulasta
Indication: Chemotherapy
Paclitaxel
End date: 2011-07-05
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Ranitidine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene
Possible Dexamethasone side effects in 49 year old female
Reported by a pharmacist from United Kingdom on 2012-06-21
Patient: 49 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Fatigue, Dyspnoea, Chest Discomfort, Chest Pain
Drug(s) suspected as cause:
Chlorphenamine
Dosage: 10 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, 2x/day
Administration route: Oral
Domperidone
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: 20mg, daily
Administration route: Oral
Granisetron
Dosage: 1 mg, 2x/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg, every two weeks
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Paclitaxel
Dosage: 300 mg, every 2 weeks
Start date: 2011-06-21
End date: 2011-07-05
Pegfilgrastim
Dosage: 6 mg, 1x/day
Indication: Chemotherapy
Ranitidine
Dosage: 50 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate; Biotene Mouthwash
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-15
Patient:
Reactions: Anaemia, Multiple Myeloma, Toxicity To Various Agents, Hypokalaemia, Death, Hypophosphataemia, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Indication: Multiple Myeloma
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient:
Reactions: Anaemia, Toxicity To Various Agents, Multiple Myeloma, Hypokalaemia, Death, Hypophosphataemia, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Indication: Multiple Myeloma
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Page 1 Next >>
|